Navigation Links
IRIDEX Reports Record 2012 Fourth Quarter Results
Date:2/28/2013

es Act of 1933, as amended, and Section 21E of the Securities Act of 1934, as amended, relating to the size and growth of and trends in the markets in which the Company operates, the success of the Company's development, marketing and sales efforts, MicroPulse laser therapy, the Company's growth strategy, the Company's acquisition strategy, sales revenue growth, operational plans, profitability, the Company's projected fiscal 2013 financial results and the Company's share repurchase program. These statements are not guarantees of future performance and actual results may differ materially from those described in these forward-looking statements as a result of a number of factors.  Please see a detailed description of these and other risks contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2011 and Quarterly Reports on Form 10-Q for the fiscal quarters ended March 31, 2012, June 30, 2012 and September 29, 2012 which were filed with the Securities and Exchange Commission. Forward-looking statements contained in this announcement are made as of this date and will not be updated.

TABLES FOLLOW

 IRIDEX CorporationCondensed Consolidated Statements of Operations(In thousands, except per share data)(unaudited)Three Months EndedTwelve Months EndedDecember 29,December 31,December 29,December 31,2012201120122011Total revenues

$
9,228$
8,620$
33,859$
33,159Cost of revenues

4,8904,34217,51316,869Gross profit

4,3384,27816,34616,290Operating expenses:Research and development

1,0911,1664,3853,913Sales and marketing

2,0342,1477,8957,458General and administrative

9081,0664,9264,259Legal settlement, net of expenses

-(1,274)-(1,274)Total operating expenses

4,0333,10517,20614,356Income (loss) from operations

3051,173(860)1,934Legal settlement

--800800Other expense, net

(18)(250)(210)(296)Income (loss) from continuing opera
'/>"/>

SOURCE IRIDEX Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. IRIDEX Announces Fourth Quarter and Full Year 2012
2. IRIDEX Announces Preliminary Unaudited Revenues for 2012 Fourth Quarter and Year End
3. IRIDEX Corporation Announces Preliminary Results of its Tender Offer
4. IRIDEX Announces FDA 510(k) and CE Clearance of New Laser Delivery System for Fast, Non-invasive Treatment of Serious Retinal Diseases
5. QUANTEL Medical Signs Global Licensing Agreement with IRIDEX
6. IRIDEX Announces Tender Offer to Purchase up to 487,500 Shares of its Common Stock
7. IRIDEX Reports 2012 Third Quarter Results
8. IRIDEX Announces Third Quarter 2012 Conference Call and Release Date
9. IRIDEX Appoints Chairman William M. Moore as Interim President & CEO
10. IRIDEX Reports 2012 Second Quarter Results
11. IRIDEX Announces Second Quarter 2012 Conference Call and Release Date
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... /PRNewswire-iReach/ -- Gateway Analytical announced today that they ... Annual Global Pharma Manufacturing Summit in ... The Global Pharma Manufacturing Summit offers a networking ... biologic pharmaceutical manufacturing. The conference is focused on ... such as the increasing pressure to grow and ...
(Date:8/28/2014)... Orthopaedics, the Official Joint Replacement Products of the PGA TOUR ... to golf fans at the next stop of the FedEx ... company,s fan destination – "The Stryker Mobility Zone" – will ... TPC Boston in Norton, MA starting ... the Deutsche Bank Championship, Stryker will be providing golf fans ...
(Date:8/28/2014)... NEW YORK , Aug. 28, ... a new market research report is ... ADHD Therapeutics to 2020 - Broadened ... to Drive Market Growth despite Patent ... ADHD Therapeutics to ...
Breaking Medicine Technology:Gateway Analytical to Promote Particulate Identification Services at the 9th Annual Global Pharma Manufacturing Summit 2Gateway Analytical to Promote Particulate Identification Services at the 9th Annual Global Pharma Manufacturing Summit 3Stryker, Official Joint Replacement Products Of The PGA TOUR, Heads To Boston For The Deutsche Bank Championship 2Stryker, Official Joint Replacement Products Of The PGA TOUR, Heads To Boston For The Deutsche Bank Championship 3Stryker, Official Joint Replacement Products Of The PGA TOUR, Heads To Boston For The Deutsche Bank Championship 4Stryker, Official Joint Replacement Products Of The PGA TOUR, Heads To Boston For The Deutsche Bank Championship 5ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 2ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 3ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 4ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 5ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 6ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 7ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 8
(Date:8/29/2014)... CA (PRWEB) August 29, 2014 According ... a lawsuit against Pfizer Inc., Greenstone LLC and Pfizer ... with congenital birth defects as a result of ... defect lawsuit was filed in St. Clair County Circuit ... to the lawsuit, the defendant companies allegedly concealed the ...
(Date:8/29/2014)... 2014 Under Section 946.300, Qualifications for ... “The physician shall not…advertise in a cultivation center or ... What the state of Illinois has done is create ... potential patients entering their care. The goal is to ... pharmacies and with typical prescription medications. Medical steering is ...
(Date:8/28/2014)... FL (PRWEB) August 29, 2014 ... that brings pharmaceutical industry precision to the development ... zoning approval for its primary location in Sarasota ... and decisively with a total commitment to attracting ... forward to creating," says David Wright, President and ...
(Date:8/28/2014)... Arlington, Massachusetts (PRWEB) August 29, 2014 ... company that solves some of the healthcare industry's ... design concepts that radically rethink health. Involution ... edge of technology creating software solutions for clients ... and Walgreens. , As part of the studio's ...
(Date:8/28/2014)... UWDress.com, an internationally famous designer and leader ... fashionable assortment of fall bridesmaid dresses for ... customers, the company is now providing big discounts for ... fall bridesmaid outfits are offered in many fashionable colours. ... priced less than $190. UWDress.com’s kind officials always take ...
Breaking Medicine News(10 mins):Health News:The Law Office of Melinda J. Helbock A.P.C. Comments on Zoloft Birth Defect Lawsuit 2Health News:Medical Marijuana Company Provides Solution for Illinois Marketing Regulations 2Health News:Sarasota County Approves Zoning for Leading Medical Cannabis Firm AltMed 2Health News:Top Three Open Source Design Concepts that Rethink Health from Involution Studios 2Health News:Top Three Open Source Design Concepts that Rethink Health from Involution Studios 3Health News:Fashionable Fall Bridesmaid Dresses From UWDress.com 2
... primary biliary cirrhosis may lead to new treatments, researchers ... have found genetic variations that appear to increase the ... that can destroy the liver. , Primary biliary cirrhosis ... in the liver. It is a condition that mostly ...
... BEER-SHEVA, ISRAEL, June 10, 2009 Metoclopramide, a drug approved ... significant risks for the fetus according to a large cohort ... New England Journal of Medicine , "The Safety of ... Engl J Med 2009;360:24 June 11, 2009). According ...
... , WASHINGTON, June 10 Trust for America,s Health (TFAH) ... and Pensions (HELP) for including strong prevention and public health ... health of Americans. , , "Our nation will ... do a better job of keeping Americans healthier and preventing ...
... Survey Conducted with American Dietetic Association Shows Lack of Reimbursement ... June 10 Ninety-six percent of primary care physicians believe ... nutrition to treat and manage chronic disease, according to a ... currently pay significant attention to nutrition in the context of ...
... Researchers at The Wistar Institute have defined a key ... process of aging. The study, published June 11 in ... of aging that could point toward new anti-aging strategies ... that a class of proteins called sirtuins promotes fitness ...
... 10 RPD Media Associates, LLC, a full-service video content marketing ... , , ACW recognized RPD Media for producing: an ... Westchester Orthopaedic Institute; a radio spot series for WHUD ... Minute ; a feature film for The Snowball Gala ...
Cached Medicine News:Health News:Genetic Links to Rare Liver Disease Found 2Health News:Genetic Links to Rare Liver Disease Found 3Health News:Off-label morning sickness drug deemed safe for fetuses -- Ben-Gurion U. researchers 2Health News:TFAH Applauds 'Affordable Health Choices Act' for Making Prevention a Cornerstone of Health Reform 2Health News:TFAH Applauds 'Affordable Health Choices Act' for Making Prevention a Cornerstone of Health Reform 3Health News:TFAH Applauds 'Affordable Health Choices Act' for Making Prevention a Cornerstone of Health Reform 4Health News:More Than 9 in 10 Primary Care Physicians Say U.S. Health Care System Should Place Greater Emphasis on Nutrition to Manage Chronic Disease 2Health News:More Than 9 in 10 Primary Care Physicians Say U.S. Health Care System Should Place Greater Emphasis on Nutrition to Manage Chronic Disease 3Health News:More Than 9 in 10 Primary Care Physicians Say U.S. Health Care System Should Place Greater Emphasis on Nutrition to Manage Chronic Disease 4Health News:Wistar Institute team finds key target of aging regulator 2Health News:RPD Media Wins Four 'Big W' Awards by the Advertising Club of Westchester County 2
Intended for the quantitative determination of creatinine in serum, plasma, or urine. Reaction: Endpoint. Wavelength: 340 nm. Linearity: 10 mg/dL (880 mol/L). Two vials, dry powder reagents....
For the qualitative determination of magnesium in serum....
Intended for the quantitative determination of magnesium in serum. Wavelength: 340 nm. Linearity: 9.7 mg/dL (4 mmol/L). Two vials, dry powder reagents....
For the quantitative determination of total glucose in serum....
Medicine Products: